SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: D.Right who wrote (641)9/1/1997 8:12:00 PM
From: Henry Niman   of 2173
 
Dan, Check out the diabetes board. Rezulin is currently being used off label and patients are not shy about telling others how well they are doing or telling their Dr. So far Rezulin is only approved for type II patients on insulin. Check out the board (misc.health.diabetes). I think you will be surprised (and not too many of the posters are named Henry :-)). You can also check out the diabetes archive at:
lehigh.edu
As far as the diabetes trials are concerned, the more approved uses the better, and large trials are expensive, especially prevention trials (and LGND has 2nd & 3rd generation compounds already identified and in the literature).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News